Gillette India Q1: revenue +11% YoY to ₹783 Cr, PAT +9% to ₹159 Cr, margins steady
PAT +9.44% YoY · revenue +10.79% · margins flat
₹783.02 Cr
+10.79% YoY
₹159.45 Cr
+9.44% YoY
20.23%
-0.2pp YoY
₹48.93
Gillette India opened FY27 with a steady, in-line quarter. Standalone revenue from operations rose 10.8% YoY to ₹783.0 Cr (Q1 FY26: ₹706.7 Cr) and net profit grew 9.4% YoY to ₹159.5 Cr (₹145.7 Cr), with basic EPS at ₹48.93 vs ₹44.71. Net margin held flat at 20.4% year-on-year, so profit growth tracked topline rather than outpacing it — a clean double-digit-revenue, single-digit-profit print with no one-off items on either side.
Q1 FY-2027 vs prior quarters
The margin story is one of stability, not expansion. Cost of materials consumed rose to ₹187.7 Cr and employee costs climbed to ₹61.2 Cr, but the offset came from advertising & sales promotion, which fell sharply to ₹103.3 Cr from ₹136.4 Cr a year ago (down ~₹33 Cr) — the single largest reason PBT could rise 9.5% to ₹214.0 Cr despite input-cost pressure. Lower A&P intensity supported the bottom line this quarter; whether that is phasing or a sustained pull-back is the key thing to watch, given management gives no formal earnings guidance and none is on record.
The stock went into the print at ₹7,720, up 0.9% over the past month of trading.
Both segments grew. Oral Care was the faster mover, up 18.9% YoY to ₹154.4 Cr, while the much larger Grooming franchise rose 9.0% to ₹628.7 Cr; Grooming segment profit (₹173.5 Cr, +13% YoY) carried the result while Oral Care profit was roughly flat (₹37.7 Cr vs ₹36.8 Cr). The sequential optics look soft — revenue -1.1% and PAT -17.2% QoQ versus a strong Q4 (₹192.5 Cr) — but Q4 is a seasonally heavier quarter for the business and the YoY comparison is the right read; the QoQ dip is not a deterioration in the franchise.
W1
A&P spend: sustainability of the reduced ₹103 Cr run-rate — a rebuild toward the ₹136 Cr year-ago level would compress the ~20% net margin
W2
Grooming volume/revenue trajectory (₹629 Cr, +9% YoY) under the new Sales Head appointed this quarter
W3
Oral Care momentum: whether the 18.9% YoY growth to ₹154 Cr holds as it laps easier bases
Digitally-native filing, clean text. Standalone only (Co. has no subsidiary/associate/JV per Note 3). Figures in Lakhs, converted to Cr. No exceptional items. Other comprehensive income (re-measurement of defined benefit plans) excluded from PAT as standard. Column-locked to 30-Jun-2026 (Unaudited).